| Line 30: |
Line 30: |
| | ==Clinical Signs== | | ==Clinical Signs== |
| | ==Laboratory Tests== | | ==Laboratory Tests== |
| | + | patients platelet count andfibrinogen levels will be decreased. |
| | + | PT and PTT and thrombin time increases. |
| | + | Fibrin degradation products (FDPs) are also increased. |
| | + | |
| | ==Treatment== | | ==Treatment== |
| | | | |